Nurix Therapeutics Inc (NRIX)
22.05
-0.32
(-1.43%)
USD |
NASDAQ |
Nov 22, 16:00
21.50
-0.55
(-2.49%)
After-Hours: 20:00
Nurix Therapeutics Total Assets (Quarterly): 513.60M for Aug. 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| August 31, 2024 | 513.60M |
| May 31, 2024 | 511.03M |
| February 29, 2024 | 312.67M |
| November 30, 2023 | 355.60M |
| August 31, 2023 | 308.20M |
| May 31, 2023 | 350.62M |
| February 28, 2023 | 370.15M |
| November 30, 2022 | 416.76M |
| August 31, 2022 | 459.34M |
| May 31, 2022 | 394.31M |
| Date | Value |
|---|---|
| February 28, 2022 | 437.72M |
| November 30, 2021 | 476.77M |
| August 31, 2021 | 493.07M |
| May 31, 2021 | 517.98M |
| February 28, 2021 | 396.66M |
| November 30, 2020 | 396.34M |
| August 31, 2020 | 411.87M |
| May 31, 2020 | 213.28M |
| November 30, 2019 | 44.05M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
44.05M
Minimum
Nov 2019
517.98M
Maximum
May 2021
388.42M
Average
396.66M
Median
Feb 2021
Total Assets (Quarterly) Benchmarks
| Enzo Biochem Inc | 85.76M |
| Neogen Corp | 4.503B |
| Pfizer Inc | 219.48B |
| Zymeworks Inc | 487.15M |
| Accolade Inc | 756.07M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 136.74M |
| Shareholders Equity (Quarterly) | 376.86M |
| Current Ratio | 5.285 |